The Food and Drug Administration has accepted Lykos Therapeutics' new drug application for psychedelic-assisted therapy, teeing up 2024 as a potentially transformative year for psychedelic medicine.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
